HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.30
-0.20 (-0.48%)
Sep 8, 2026, 1:30 PM CST

HeXun Biosciences Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
116.33111.91147.2233.49-5.19-42.99
Depreciation & Amortization
29.627.9123.5219.114.1911.43
Other Amortization
1.041.041.21.20.530.48
Loss (Gain) From Sale of Assets
1.631.620.010.05-0.02-0.2
Stock-Based Compensation
7.783.62--0.3-
Other Operating Activities
5.11-4.3613.97-0.07-0.050.47
Change in Accounts Receivable
10.4410.12-62.39-17.3-4.98-
Change in Inventory
3.989.56-10.98-4.6--
Change in Accounts Payable
3.11-1.071.81-0.80.42-4.3
Change in Unearned Revenue
-13.375.266.97-3.375.1-
Change in Other Net Operating Assets
-1.82-1.71-0.415.390.93-0.39
Operating Cash Flow
163.8163.89120.9243.0911.23-35.5
Operating Cash Flow Growth
-6.65%35.54%180.62%283.77%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29.24-27.29-37.29-20.67-1.23-
Sale of Property, Plant & Equipment
0.19---0.138.84
Sale (Purchase) of Intangibles
-1.91-1.57--0.64-5.96-
Investment in Securities
-180.32-129.43-100--72-
Other Investing Activities
1.91-0.09--3.97--35.78
Investing Cash Flow
-209.38-158.38-137.29-25.28-79.05-26.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--3.81-40.31-4.88-2.46-2.01
Lease Payments
-3.88-3.81-2.85-2.73-2.07-2.01
Net Debt Issued (Repaid)
-3.88-3.81-40.31-4.88-2.46-2.01
Issuance of Common Stock
266.34--12510578
Other Financing Activities
1.995.5----0.2
Financing Cash Flow
264.451.69-40.31120.12102.5475.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
218.877.21-56.68137.9334.7213.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
134.56136.6183.6322.4210-35.5
Free Cash Flow Growth
-11.72%63.36%272.98%124.19%--
Free Cash Flow Margin
43.66%46.59%29.20%17.17%20.22%-
Free Cash Flow Per Share
2.922.971.820.490.27-1.16
Levered Free Cash Flow
105.4794.9133.79.680.46-
Unlevered Free Cash Flow
106.1395.6134.4310.841.48-
Free Cash Flow After Leases
130.68132.880.7719.77.93-37.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.051.11.241.791.641.57
Cash Income Tax Paid
19.718.330.17---
Change in Working Capital
2.3322.16-64.99-10.681.47-4.69